Skip to main content
vTv Therapeutics Inc. logo

vTv Therapeutics Inc. — Investor Relations & Filings

Ticker · VTVT ISIN · US9183852048 LEI · 549300WQE5EI9R35SE66 US Manufacturing
Filings indexed 577 across all filing types
Latest filing 2026-05-13 Prospectus
Country US United States of America
Listing US VTVT

About vTv Therapeutics Inc.

https://vtvtherapeutics.com/

vTv Therapeutics is a clinical-stage biopharmaceutical company focused on developing oral, small molecule drug candidates. The company's primary commitment is to improving the lives of patients with diabetes. Its lead clinical drug candidate is cadisegliatin, a potential adjunctive therapy to insulin for the treatment of type 1 diabetes. In collaboration with development partners, vTv is also pursuing additional indications for its pipeline molecules, including type 2 diabetes and other chronic conditions.

Recent filings

Filing Released Lang Actions
424B2 - vTv Therapeutics Inc. (0001641489) (Filer)
Prospectus
2026-05-13 English
8-K - vTv Therapeutics Inc. (0001641489) (Filer)
Regulatory Filings
2026-05-13 English
S-8 - vTv Therapeutics Inc. (0001641489) (Filer)
Registration Form
2026-05-13 English
10-Q - vTv Therapeutics Inc. (0001641489) (Filer)
Interim / Quarterly Report
2026-05-13 English
8-K - VTV THERAPEUTICS INC. (0001641489) (Filer)
Regulatory Filings
2026-02-26 English
4 - VTV THERAPEUTICS INC. (0001641489) (Filer)
Director's Dealing
2026-02-18 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.